Canadian AIDS Treatment Information Exchange (CATIE)

Email

mdickie@catie.ca

Phone

T: + 416-203-7122 x 222

Web

www.catie.ca

Address

Suite 505, 555 Richmond Street West, Toronto Toronto AB Canada
About Canadian AIDS Treatment Information Exchange (CATIE)

CATIE is Canada’s source for up-to-date, unbiased information about HIV and hepatitis C. We connect people living with HIV or hepatitis C, at-risk communities, healthcare providers and community organizations with the knowledge, resources and expertise to reduce transmission and improve quality of life.

Vision:

CATIE will be a catalyst for a renewed and integrated national response to reduce the transmission of HIV and hepatitis C (HCV), and to improve the quality of life of people with HIV and HCV.

Mission:

CATIE champions and supports innovation and excellence in knowledge exchange for the prevention of HIV and HCV transmission, and the care, treatment, and support of people with HIV and/or HCV by:

Supporting and connecting people with HIV, other individuals, and organizations to develop, synthesize, share and apply HIV knowledge;
Collaborating with and building the capacity of frontline organizations to use treatment and prevention knowledge effectively;
Acting as a central contact point for the flow of comprehensive, accurate, unbiased, timely and accessible HIV and HCV information and community-based knowledge.

CATIE is a member of The National Partners in Canada’s HIV Response, a coalition of Canadian HIV/AIDS stakeholder groups representing national service organizations, frontline agencies, knowledge providers, researchers and people who are living with and vulnerable to HIV and AIDS. Working respectfully with those most affected, we strive to ensure that government decisions and private sector actions are informed by an evidence-based knowledge of the needs of the community.

Sign up to receive updates from WHA

Name(Required)
I would like to hear about(Required)

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Hepatitis and PWID/harm reduction 

 

11:35 – 11:40  

Chair: WHO – Intro and set the scene.  

 

11:40 – 11:55  

Co-chair:  EMCDDA – Monitoring viral hepatitis elimination among PWID in Europe. 

 

11:55 – 12:00 

ID 29: Ema Pos (not yet registered) 

Title: If the mountain won’t come to Mohammed: lessons from a decentralized Infectious Disease consultation. 

 

12:05 – 12:10  

ID 152: Brian Conway (Registered in person) 

Title: Community Pop-up Clinic: Cascade of Care and HCV Treatment of Vancouver’s inner-city PWID Populations.

 

12:10 – 12:15 

ID 212: Jasmine West (not yet registered) 

Title: From lived experience to lived expertise: a syndemic approach. 

 

12:15 – 12:20 

ID: 299 Mercy Nyakowa (Registered in person) 

Title: HCV and HBV prevalence and associated risk factors among people who inject drugs (PWIDs) in Kenya 

 

12:20 – 12:25 

ID: 133 Nalinikanta Rajkumar (Registered in person) 

Title: Rapid regimen of HBV vaccination: Does it work for high risk groups?  

 

12:25 – 12:30 

Q&A and closing remarks   

tHIS

 

IS 

 

BEN’S

 

 

 

BIG 

 

 

TEST

effective case finding strategies

Supported by Vir Biotechnology, Inc

During this session you will hear from hepatitis Delta expert, Dr. Maria Buti, and a patient who has lived with hepatitis Delta in a panel discussion moderated by Dr. Carey Hwang, Chief Medical Officer (interim) of Vir Biotechnology. This panel will inform perspectives on patient needs, opportunities for enhanced screening, and strengthening linkages to care.

Session Agenda

14:40 – 14:45    

Panel overview and introductions facilitated by Dr Carey Hwang (Vir Biotechnology)

14:45 – 15:05   

Panel discussion: Dr Maria Buti (University Hospital Vall d’Hebron, Spain), Milanka Barbosa, Dr Carey Hwang (Chief Medical Officer interim), Vir Biotechnology

15:05 – 15:10    

Final remarks and close